More clarity for

more patients

The AURA 10 PET-CT Imager offers surgical oncologists the opportunity to assess resected specimens intraoperatively with more clarity and for an increasing number of applications and patients. Surgeons can now operate with more confidence, but also speed up procedure time, reduce anesthesia time, and improve the chances of recovery.

More clarity for
more patients

The AURA 10 can be used for a diverse range of applications, including :

Breast conserving surgery

Breast conserving surgery

Obtain images of breast specimens while minimizing workflow disruption.

Read more
Prostate cancer surgery

Prostate cancer surgery

Conduct nerve-sparing prostatectomies with a higher chance of success.

Read more
Head & neck cancer surgery

Head & neck cancer surgery

Get an accurate view of what was resected, even in the smallest oral cancers.

Read more

Breast conserving surgery.

Surgical oncologists rely on the AURA 10 PET CT imager to obtain high-precision images of the breast specimen while minimizing the disruption of the surgical workflow.

Breast surgeons need high-precision images of resected specimens to reduce the risk of resurgery and improve the cosmetic outcome as much as possible. Unfortunately, today’s conventional intraoperative techniques for specimen evaluation are either labor-intensive or only offer limited functionality.

The new AURA PET-CT imager however makes use of the power of molecular imaging to provide surgeons with more clarity on breast specimens in a matter of minutes. This reduces the operating time, increases chances of recovery, and improves cosmetic results.

AURA 10

for breast conserving surgery:

  • Resect the target lesion with more confidence
  • Improve the cosmetic outcome for patients
  • Reduce procedure & anesthesia time
Discover AURA 10

Prostate cancer surgery.

Urology surgeons can include the AURA 10 PET-CT imager in their procedures to assess specimens intraoperatively with more certainty. This way, they can conduct nerve-sparing prostatectomies with a higher chance of success.

A clear picture of the resected tissue is crucial if you want to reduce the chances of reoperation or adjuvant therapies like radiotherapy or chemotherapy. To date, frozen sections are still most common in prostate cancer surgery. However, this technique requires a long intraoperative evaluation and anesthesia period (up to 30 minutes), which is not beneficial for the patient.

The AURA PET-CT imager on the other hand leverages the power of molecular imaging - for example using prostate specific membrane antigen (PSMA) targeted radiotracers - and delivers a high-precision image of the specimen in a matter of minutes. This speeds up procedure time, reduces anesthesia time, and improves patient outcomes.

AURA 10

for prostate cancer surgery:

  • Assess resected specimens faster and with more clarity
  • Reduce procedure & anesthesia time
  • Reduce the chances of adjuvant therapies
Discover AURA 10

Head & neck cancer surgery.

During head and neck cancer surgery, the AURA 10 PET-CT imager can give a clear, accurate view of the resected specimen. This enables surgeons to assess what was removed, even in the smallest oral cancers.

For head and neck cancer surgery, making the right decisions intraoperatively is a complex process. The number of incomplete resections is typically high, compared to other types of cancer surgery. Until now, the possibilities for intraoperative specimen assessment have been limited. Frozen sections are widely used, but unfortunately, they prolong the operation time significantly.

The AURA PET-CT imager however makes use of the power of molecular imaging to provide surgeons with more clarity on neck or head specimen in a matter of minutes. The result is a shorter operating time and a possible reduction of the risk of resurgery or adjuvant therapies for the patient.

AURA 10

for head & neck cancer surgery:

  • Get a clear view of what was resected, even in small oral cancers
  • Reduce procedure & anesthesia time
  • Possibly reduce the probability of resurgery or adjuvant therapies
Discover AURA 10

Subscribe to
our newsletter